Erkang Pharmaceuticals (300267.SZ): Diprophylline Injection Approved for Registration

date
29/07/2025
Tencent Financial News APP News, Yekang Pharmaceutical (300267.SZ) announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration, and the company's dihydroxypropyl theophylline injection has been approved for registration.